A Study Of Relation Between Autism And Overweight In Center Of Care Of Children With Special Need In Ain Shams University | ||||
| مجلة دراسات الطفولة | ||||
| Article 1, Volume 22, Issue 01.2019 - Serial Number 82, January 2019, Page 1-10 PDF (3.68 MB) | ||||
| Document Type: المقالة الأصلية | ||||
| DOI: 10.21608/jsc.2019.32517 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| عزة خضر* ; محمد صلاح الدين مصطفى; ايهاب محمد عيد | ||||
| قسم الدراسات الطبية للأطفال کلية الدراسات العليا للطفولة جامعة عين شمس | ||||
| Abstract | ||||
| Abstract Background: Obesity is a major public health problem and the prevalence of obesity is increasing in all countries. Obesity in children has become a significant health concern, and the prevalence of childhood obesity has tripled over the last twenty years. Data from the National Health & Nutrition Examination Survey (NHANES) indicate that nearly a third of children in the general population are overweight or obese. Autism is associated with abnormal eating habits and sedentary life lead to obesity. Objective: To determine the frequency of overweight among autistic children, and to study relation to diet, medication, sleep, habitand physical activity. Methodology: A cross-sectional study included 30 autistic childern from the center of care of children with special need, Ain Shams University. All children were subjected to a clinical interview derived from AIN SHAMS Sheet ,measuring weight , height, BMI, CARRS and IQ. All ASD children were subjected to the following: Personal data, Birth History, Dietetic History, Family History, Current and Past Medical Information History, Physical activity & sleep, Eating Behaviour Questionnaire, Anthropometric measurements. Results: BMI showed that 10 cases of autistic children were overweight with high BMI percentile (P =0.43), they were mild autism. 80.0% of ASD children had normal appetite, (20%) of the children had increased appetite. Consumption of one unit of fruits represented 53.3%, 2 unit 6.7%. Consumption of vegetable one unit represented 63.3%, two unit 6.7%.16.7%) was using otomox and (83.3%) were not subjected to drugs. 33.3% was using risperidone and (66.7%) were not subjected. Conclusion: Autistic children tend to be overweight and obese because of bad eating habit, medication sedentary life. Keywords: Obesity, autism ,epidemiology , Body Mass Index, Children Introduction: Obesity in children has become a significant health concern, and the prevalence of childhood obesity has tripled over the last twenty years. Data from the National Health & Nutrition Examination Survey (NHANES) indicate that nearly a third of children ages (2-19years) in the general population are overweight or obese.1 Evidence from clinic-based studies and nationally representative surveys suggests that children with autism spectrum disorders (ASD) have a prevalence of obesity at least as high as that seen in typically developing children. While significant efforts are underway to understand and treat obesity in the general pediatric population, relatively little work has focused on children with ASD. In general, children who are obese are likely to remain so as adults, and excess weight substantially increases risk for chronic diseases such as diabetes, cardiovascular disease, and certain cancers.2 Given the increasing prevalence of ASD, the prevention of secondary conditions associated with obesity in children in this population is a pressing public health issue, with implications for independent living and quality of life. 3 Objective: The purpose of this study is to find the frequency of overweight in ASD children and the risk factors that may experience. Methodology: Study Design: Cross section study. The study is a cross sectional case study aiming to study relation between overweight and autism in children. Subjects : The study was conducted in center of care of children with special need in Ain shams university representing the over a period starting from March, 2018to end of August, 2018. The autistic children were selected on the basis of the following criteria: nclusion Criteria: Patients diagnosed according to DSM VI as having autism Age range from 5 years - 18 years. Both sexes Methods: All ASD children were subjected to the following: Personal data: Name, date of birth and age, sex, residency place, order of birth, number and of brothers and sisters. Socioeconomic status is assessed through: parents’ educational level, parents’ job, housing characteristic. Birth History: including previous miscarriages or stillbirths, health Problems during pregnancy, labor circumstances, and child’s Condition at and after birth General examination. Dietetic History: including feeding problems and the last day dietary recall Local. Family History: of medical diseases, epilepsy, developmental problems as ADHD, Language and Speech problems, Intellectual disability and psychiatric problems. Current and Past Medical Information History: Physical activity & sleep Eating Behaviour Questionnaire CARS and IQ obtained from the patient file Complete Medical Examination Anthropometric measurements: Anthropometric measurements are done then plotted against the corresponding WHO Z Score and percentiles growth charts (Height measurement (Ht), Weight measurement (Wt) and Body Mass Index (BMI). The software consisted of three modules: anthropometric calculator, individual assessment, and nutritional survey. Only the anthropometric calculator module was used to calculate the corresponding percentile and Z score for children. Limitations of the study: Some caregivers were uncooperative. Much time was needed for evaluation of one child. Ethical Consideration: Approval of the medical ethics committee of the national research center and the ethical committee of the institute for post graduate child hood studies was obtained. A full explanation of the study will be provided to the patients a written consent was taken from the patient or guardians. | ||||
| Keywords | ||||
| Obesity; autism; Epidemiology; Body Mass Index; children الأطفال - مؤشر کتلة الجسم – زيادة الوزن- طيف التوحد | ||||
| References | ||||
|
References: Maayan L, Correll CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. Journal of child and adolescent psychopharmacology. 2011;21(6):517–35. doi: 10.1089/cap.2011.0015. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433–8. doi: 10.1161/01.CIR.0000111245.75752.C6. McDougle CJ, Stigler KA, Erickson CA, Posey DJ. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. [Accessed November 25, 2012];The Journal of clinical psychiatry. 2008 69(Suppl 4):15–20. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18533764. [PubMed] McDougle CJ, Scahill L, McCracken JT, et al. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. [Accessed January 21, 2013];Child and adolescent psychiatric clinics of North America. 2000 9(1):201–24. Available at:http://www.ncbi.nlm.nih.gov/pubmed/10674197. Posey DJ, Stigler KA, Erickson CA, McDougle CJ. Antipsychotics in the treatment of autism. The Journal of clinical investigation. 2008;118(1):6–14. doi: 10.1172/JCI32483 Aman MG, Arnold LE, McDougle CJ, et al. Acute and long-term safety and tolerability of risperidone in children with autism. Journal of child and adolescent psychopharmacology. 2005;15(6):869–84. doi: 10.1089/cap.2005.15.869. Siegel M, Beaulieu AA. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice. Journal of autism and developmental disorders. 2012;42(8):1592–605. doi: 10.1007/s10803-011-1399-2. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533–40. doi: 10.1542/peds.3782. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2009;48(11):1110–9. doi: 10.1097/CHI.0b013e3181b76658. De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European psychiatry : the journal of the Association of European Psychiatrists. 2011;26(3):144–58. doi: 10.1016/j.eurpsy.2010.09.011. Cohen SA, Fitzgerald BJ, Khan SRF, Khan A. The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment. [Accessed January 21, 2013];The Journal of clinical psychiatry. 2004 65(1):110–3. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14744179. Malone RP, Delaney MA, Hyman SB, Cater JR. Ziprasidone in adolescents with autism: an open-label pilot study. Journal of child and adolescent psychopharmacology. 2007;17(6):779–90. doi: 10.1089/cap.2006.0126. Golubchik P, Sever J, Weizman A. Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial. Clinical neuropharmacology. 2011;34(6):216–9. doi: 10.1097/WNF.0b013e31823349ac Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatrica Scandinavica. 1999;100(1):3–16. doi: 10.1111/j.1600-0447.1999.tb10908.x. Panariello F, De Luca V, De Bartolomeis A. Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies. [Accessed February 6, 2013];Schizophrenia Research and Treatment. 2010 2011Available at: http://www.hindawi.com/journals/sprt/2011/459284/abs/ Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-Histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003;28(3):519–26. Matsui-Sakata A, Ohtani H, Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. [Accessed February 6, 2013];Drug metabolism and pharmacokinetics. 2005 20(5):368–78. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16272755. دراسة العلاقة بین الذاتویة وزیادة الوزن فى مرکز ذوى الاحتیاجات الخاصة جامعة عین شمس عزة خضر* – محمد صلاح الدین مصطفى** – إیهاب محمد عید** * طبیب أطفال بمرکز الرعایة الصحیة بقلیوب ** قسم الدراسات الطبیة للأطفال کلیة الدراسات العلیا للطفولة جامعة عین شمس الخلفیة: من المعروف أن السمنة هی مشکلة صحیة عامة کبیرة وأن انتشار البدانة یتزاید فی جمیع البلدان المرتبطة بالتوحد مع عادات الأکل غیر العادیة والحیاة المستقرة تؤدی إلى السمنة ، والتی تستلزم تناول کمیات کبیرة من الکربوهیدرات الغذائیة والغذاء السکریة. الهدف:لتحدید وتیرة السمنة بین الأطفال المصابین بالتوحد ، ودراسة العلاقة مع النظام الغذائی ، والأدویة ، والنوم ، والعادة ، والنشاط البدنی. المنهجیة: کانت العینة عشوائیة للاطفال المتوحدین (Autistic childern) وقد تم اختیار الحالات فی أحد المواقع (مرکز رعایة الأطفال ذوی الاحتیاجات الخاصة جامعة عین شمس). تم إجراء 30 حالة من خلال 4 أشهر تم إخضاع جمیع المرضى لمقابلة سریریة مستمدة وسؤالهم عن قیاس الوزن ، الطول ، مؤشر کتلة الجسم ، CARRSو IQوالعادات الغذائیة للطفل ومشاهدته للتلفاز أثناء الأکل واذ اکان احد إخوته مصابا بالتوحد ام لاواذا کان والدیه اقارب وهل نومه طبیعى ام لا وهل یمارس ریاضة ام لا النتائج: حوالى 30% من حالات التوحد تعانى من زیادة الوزن و 20% یعانون من اضطراب الشهیة. الخلاصة: الأطفال المتوحدین یمیلون إلى زیادة الوزن والبدانة بسبب عادة الأکل السیئة ، وعدم ممارسة ریاضة.
| ||||
|
Statistics Article View: 396 PDF Download: 507 |
||||
